Back to Blog

Why Does CMPA Seem So Common Now?

Proven cow's milk allergy affects under 1% of babies, yet far more get the label. Here's what drives the gap and what it means for your family.

CMPA Baby Editorial Team9 min read

Written by CMPA Baby Editorial Team · Source-checked September 2026 · Not a substitute for medical advice.

Watercolor illustration of a parent on a sofa at night scrolling her phone by the glow of a table lamp while a baby sleeps on her chest

If it feels like half the babies in your parents' group have been told they might have a cow's milk allergy, you are not imagining it. The number of babies given the label has climbed sharply. So why is CMPA so common now? The short answer: the symptoms on CMPA checklists are common in healthy babies, the step that confirms the diagnosis is often skipped, and challenge-proven CMPA still affects under 1% of infants. Here is what the research shows: how common CMPA really is, why suspected cases far outnumber proven ones, and why "more diagnosed" is not the same as "more allergic".

Key takeaways

  • Challenge-proven cow's milk allergy affected 0.54% of infants in Europe's largest birth cohort, ranging from under 0.3% to 1% between countries.[1]
  • Parent-perceived rates are often around 10%, and ESPGHAN's 2024 position paper states that over-diagnosis is more common than under-diagnosis.[2]
  • The symptoms that most often trigger a CMPA label (troublesome crying, spit-up, rashes) are each reported in 15–20% of all babies.[3]
  • In England, specialist formula prescriptions rose around 500% between 2006 and 2016 with no reliable evidence of a matching rise in true allergy.[4]
  • Allergic disease overall has risen, but a delayed-type diagnosis is only confirmed when milk is reintroduced and symptoms return; skipping that step is why many labels stick.[2][5][10]

How common is CMPA, really?

CMPA stands for cow's milk protein allergy: an immune reaction to the proteins in cow's milk. (See our guide to CMPA, CMA, CMPI and MSPI.) The honest answer to "how common is it" depends on how you count.

The most reliable numbers come from birth cohorts, which follow thousands of babies from birth and confirm every suspected case with a supervised food challenge (giving milk under medical observation). In EuroPrevall, 9,336 babies across nine European countries were followed to age two: allergy was suspected in 358 and confirmed in 55, an incidence of 0.54%, ranging from under 0.3% in Lithuania, Germany and Greece to 1% in the Netherlands and the UK.[1]

Older estimates of 2–3% in early childhood are still widely quoted,[2][5] and some patient charities cite figures as high as 7% of babies under one.[9] An older American Academy of Pediatrics parent resource puts reactions to something in the mother's diet at two or three in every hundred exclusively breastfed babies;[8] more recent cohort data on cow's milk specifically suggest closer to 0.5–0.7%.[2]

ESPGHAN, Europe's pediatric gastroenterology society, concluded in 2024: "In all studies, the prevalence according to the outcome of a double-blind placebo-controlled food challenge is below 1%, while the prevalence based on the perception of parents is often reported to be around 10%."[2]

Same condition, very different numbers

How CMPA was countedTypical figureSource
Parents' perception that their baby reacts to milkAround 10%ESPGHAN 2024[2]
Older guideline estimate, early childhood2–3%ESPGHAN 2012 figure, cited in ESPGHAN 2024[2]; iMAP[5]
Confirmed by supervised food challenge, nine European countries0.54% (under 0.3% to 1%)EuroPrevall[1]
Confirmed in exclusively breastfed three-month-olds0.5–0.7%EAT study data cited by ESPGHAN[2]

That gap is the whole story of why CMPA seems so common.

Why is CMPA so common now? Suspected cases outnumber proven ones

Normal baby behaviour overlaps with the symptom list

Non-IgE CMPA, the delayed type behind most suspected cases in UK primary care, has no symptom of its own.[2] (In EuroPrevall, most challenge-confirmed cases were actually the IgE type.[1]) (IgE is the antibody behind fast, immediate reactions.) ESPGHAN puts it bluntly: with the exception of anaphylaxis, "there are no specific symptoms of allergy".[2]

Munblit and colleagues, writing in JAMA Pediatrics in 2020, noted that challenge-proven CMPA affects roughly 1% of infants, while troublesome crying, vomiting or rashes are each reported in 15–20%.[3] In the UK EAT cohort, 74% of babies had at least two "mild-to-moderate" guideline symptoms in at least one month between three and twelve months of age.[2] A checklist that flags three in four healthy babies cannot, on its own, tell you which baby is allergic.

ESPGHAN is equally direct about stools: changes in stool pattern, feeding aversion or occasional flecks of blood "are common and in general should not be considered as diagnostic of CMA".[2] Such symptoms are a reason to talk to a clinician, not a diagnosis in themselves. Our article on five early signs of CMPA covers the patterns that raise genuine suspicion.

The confirming step is often skipped

For delayed CMPA there is no blood or skin test that gives a yes or no. The diagnosis rests on a short trial without cow's milk protein, typically 2–4 weeks, followed by deliberately bringing milk back to see whether symptoms return.[2] UK NICE guidance describes the same 2–6 week elimination and reintroduction, with dietitian support.[6]

The reintroduction is the part that gets dropped. Yet babies settle on their own as they mature, so improvement during an elimination trial proves nothing by itself. The international iMAP guideline calls reintroduction "of ultimate importance to confirm the diagnosis" and warns that without it many infants continue "unnecessarily on an expensive and nutritionally demanding diet".[5] ESPGHAN calls the challenge after a short elimination "the cornerstone of the diagnosis".[2] See how CMPA is diagnosed.

Is CMPA overdiagnosed? What the evidence says

Yes, and this is not a fringe view. The very first consensus statement in ESPGHAN's 2024 paper reads: "Over-diagnosis of CMA is common. The prevalence of authenticated cow's milk allergy in infants and children is <1%." It adds that both over- and under-diagnosis carry potential long-term harms.[2]

In 2018 Dr Chris van Tulleken reported in The BMJ that specialist formula prescriptions in England had risen by around 500% between 2006 and 2016, to more than 600,000 a year, while NHS spending rose by around 700% to over £60 million annually, with no reliable data showing a rise in true incidence. He also documented formula-industry funding of professional bodies, medical education and some guideline authors.[4]

Munblit's team then examined nine CMPA guidelines from 2012 to 2019: seven suggested considering milk allergy for crying, regurgitation or rashes, and 81% of guideline authors reported a conflict of interest with formula manufacturers. The authors also estimated that for more than 99% of infants with proven CMPA, the breast milk of a mother who eats dairy contains too little milk protein to trigger a reaction.[3]

For balance, ESPGHAN also notes that non-IgE CMPA may be under-recognised in some places, and that the same UK guidelines were linked to fewer reflux-medicine prescriptions, so their effect is mixed.[2] The figures are British; the symptom overlap is universal.

Awareness, social media and the CMPA label

Some of the rise is simply greater awareness. ESPGHAN lists "changes in perception" alongside environmental and dietary change as reasons recorded allergy has increased,[2] and the BMJ investigation documented industry-designed websites and online newborn-feeding advice platforms, including parenting forums, aimed directly at new parents.[4]

Awareness is not a bad thing; delayed milk allergy can be missed as well as over-called.[2] The problem is that awareness without the confirming step produces labels rather than diagnoses. Lactose intolerance, for instance, is a reaction to milk sugar rather than an immune reaction to milk protein, and UK guidance treats it as a separate issue.[6] One practical consequence: lactose-free milk and lactose-free formula still contain cow's milk protein, so they are not a substitute for the formula or diet a clinician recommends for CMPA.[2] Our CMPA vs lactose intolerance article explains the difference.

Are more babies actually allergic? The real drivers

Separately from over-diagnosis, allergic disease as a whole has genuinely increased in wealthier countries, which ESPGHAN attributes to "complex environmental, lifestyle and dietary changes".[2] The leading explanations are hypotheses:

  • The hygiene hypothesis proposes that early exposure to a wide range of microbes teaches the immune system to tolerate harmless things like food proteins; children with older siblings have lower rates of allergic disease.[10]
  • The microbiome hypothesis refines this: disruption of the gut's bacterial community in early life appears to precede food allergy. Caesarean birth and early antibiotics have been linked to more allergic conditions, and a wider variety of first-year foods to lower food allergy risk.[10]

"Associated with" is not "causes": these links come from studies of association, and the same 2020 review notes that routine probiotics to prevent allergy are not currently recommended.[10] This story is real, but it does not explain a tenfold gap between what parents suspect and what challenges confirm. Two curves are climbing, one slowly and one steeply, for different reasons.

If your baby was diagnosed and it turned out to be something else

This is a common outcome, and not a sign that anyone did anything foolish. Clinicians see a distressed baby, have no specific test to reach for, and know a short, time-limited trial off milk is guideline-endorsed. The weak point is the follow-through, not the concern.

Remember, too, that "grew out of it" and "never had it" can look identical from the outside. In EuroPrevall, 22 of the 32 confirmed-CMPA babies re-tested a year after diagnosis (69%) tolerated milk, including every child with the non-IgE type, though the numbers are small.[1] Our article on whether babies outgrow CMPA covers the timelines.

ESPGHAN observes that many breastfeeding mothers are placed on elimination diets that were never warranted, at some cost to their own nutrition and sometimes to breastfeeding itself.[2] Raise it at your next appointment, and please do not change your own or your baby's diet on the strength of an article, including this one.

A clear record beats memory: note feeds, symptoms and timing so the pattern, or its absence, is visible at the next appointment. The CMPA Baby app is built for keeping that record between visits, and our free hidden milk ingredients label checklist helps if a supervised elimination trial is part of your plan.

Emergency signs. A small number of babies have the immediate, IgE type of milk allergy, and a severe reaction (anaphylaxis) is a medical emergency. If your baby has difficulty breathing, a swollen tongue or throat, has skin, lips or tongue that turn pale, blue or grey, or becomes floppy, or develops sudden widespread hives with vomiting after a feed, use epinephrine (adrenaline) if it has been prescribed and call 911 in the US, 999 in the UK or your local emergency number straight away.[7][11]

Talk to your child's clinician

If your baby has a CMPA label, or you suspect one, ask: Was the diagnosis confirmed by reintroduction, and if not, when is that planned? Which symptoms pointed to milk rather than normal infancy? Is a dietitian involved? This is not about doubting your doctor; it is about making sure the label your baby carries has been tested, because proven CMPA is far rarer, and far more manageable, than the headlines suggest. For the foundations, start with what CMPA actually is.

Frequently asked questions

Is CMPA overdiagnosed?

The evidence says yes. ESPGHAN's 2024 position paper states that over-diagnosis of cow's milk allergy is common and more frequent than under-diagnosis, with challenge-proven prevalence below 1% while parent-perceived rates are often around 10%. Under-diagnosis still happens too, which is why a supervised elimination-and-reintroduction process matters.

Why does CMPA seem so common in babies?

Mostly because the symptoms on CMPA checklists (crying, spit-up, rashes, stool changes) are each reported in 15–20% of all babies, so many healthy infants tick the boxes. Greater awareness, guideline symptom lists and formula marketing have widened the net, and the reintroduction step that would rule CMPA out is often skipped.

How common is CMPA really?

In the EuroPrevall birth cohort, challenge-proven cow's milk allergy affected 0.54% of infants, ranging from under 0.3% to 1% across nine European countries. Older estimates of 2–3% in early childhood are still quoted, and every study that confirmed cases with a food challenge found under 1%.

Can an exclusively breastfed baby have CMPA?

Yes, but it is uncommon. Recent cohort data put it at roughly 0.5–0.7% of exclusively breastfed three-month-olds, and researchers estimate that for over 99% of babies with proven CMPA, the amount of milk protein in breast milk is too small to trigger a reaction. Talk to your clinician before changing your own diet.

Do more diagnoses mean more babies are allergic?

No. Allergic disease overall has risen over recent decades, likely from environmental, lifestyle and dietary changes, but that slow rise does not explain a tenfold gap between suspected and challenge-proven cases. Most of the increase in CMPA labels reflects more suspicion and more prescribing, not more confirmed allergy.

How is a delayed CMPA diagnosis actually confirmed?

By a short diagnostic elimination of cow's milk protein, usually 2–4 weeks (NICE allows 2–6), followed by planned reintroduction to see whether symptoms return. Symptom scores such as CoMiSS are awareness tools and are not diagnostic on their own.

Sources

  1. Incidence and natural history of challenge-proven cow's milk allergy in European children – EuroPrevall birth cohort (Schoemaker et al., Allergy 2015;70:963–972) PubMed / National Library of Medicine (2015)
  2. An ESPGHAN Position Paper on the Diagnosis, Management, and Prevention of Cow's Milk Allergy (Vandenplas et al., JPGN 2024;78:386–413, doi:10.1097/MPG.0000000000003897) ESPGHAN (2024)
  3. Assessment of Evidence About Common Infant Symptoms and Cow's Milk Allergy (Munblit et al., JAMA Pediatrics 2020;174:599–608) JAMA Pediatrics (2020)
  4. Overdiagnosis and industry influence: how cow's milk protein allergy is extending the reach of infant formula manufacturers (van Tulleken, BMJ 2018;363:k5056, doi:10.1136/bmj.k5056) – university summary Brighton and Sussex Medical School (2018)
  5. iMAP guideline: Better recognition, diagnosis and management of non-IgE-mediated cow's milk allergy in infancy (Venter et al., Clin Transl Allergy 2017;7:26) PubMed Central / National Library of Medicine (2017)
  6. Food allergy in under 19s: assessment and diagnosis (Clinical guideline CG116, 2011; reviewed 2018) NICE (UK) (2018)
  7. Food allergies in babies and young children (page last reviewed October 2024) NHS (UK) (2024)
  8. Infant Allergies and Food Sensitivities American Academy of Pediatrics (HealthyChildren.org) (2009)
  9. Cow's Milk Allergy Allergy UK
  10. The Role of the Microbiome in Food Allergy: A Review (Nance et al., Children 2020;7:50) PubMed Central / National Library of Medicine (2020)
  11. Anaphylaxis (page last reviewed 21 June 2023) NHS (UK) (2023)

Ready to get started?

Keep your observations organized with CMPA Baby, or download our free label-reading checklist.